IDEAYA Biosciences (IDYA) Operating Expenses (2018 - 2026)

IDEAYA Biosciences has disclosed Operating Expenses across 9 years of filings, most recently posting $115.1 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at $115.1 million, up 36.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $408.7 million (up 11.27% YoY), and the FY2025 annual result was $378.0 million, up 13.19% from the prior year.
• Operating Expenses came in at $115.1 million for Q1 2026 at IDEAYA Biosciences, up from $105.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $151.1 million in Q4 2024 to a low of $25.6 million in Q1 2022.
• The 5-year median for Operating Expenses is $51.0 million (2024), against an average of $64.6 million.
• Across the five-year window, Operating Expenses soared 229.71% in 2024 and slumped 30.23% in 2025, its largest moves.
• IDEAYA Biosciences' Operating Expenses stood at $30.5 million in 2022, then soared by 50.46% to $45.8 million in 2023, then jumped by 229.71% to $151.1 million in 2024, then plunged by 30.23% to $105.4 million in 2025, then advanced by 9.16% to $115.1 million in 2026.
• The last three Operating Expenses figures came in at $115.1 million (Q1 2026), $105.4 million (Q4 2025), and $99.4 million (Q3 2025), per Business Quant data.